Details.
Minimally invasive Holmium Laser Enucleation of the Prostate treatment for benign prostatic hyperplasia. The procedure uses a holmium laser to remove obstructive prostate tissue, relieving urinary symptoms and improving urinary flow. It is performed under general or spinal anaesthesia, with the removed tissue sent for pathology analysis. Typically recommended for moderate to severe urinary symptoms caused by BPH, particularly when medication or other non-surgical treatments have been ineffective or the prostate is significantly enlarged. Usually performed as an inpatient procedure, with a temporary urinary catheter removed within a day or two and hospital stays commonly lasting one to two days. Normal activities can generally be resumed within a few weeks. Potential risks include bleeding, urinary tract infection, urinary incontinence and temporary difficulty with urination.